Vitrolife Release: Report On Operations 2013: High Growth And Improved Profitability

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Fourth quarter

Continuing operations:

· Sales growth was 27 percent in local currency. Sales amounted to SEK 124 (98) million, corresponding to an increase of 26 percent in SEK.
· Operating income (EBIT) amounted to SEK 22 (12) million, corresponding to an operating margin of 18 (12) percent. The quarter was affected by the write-down of intangible assets with regard to Labware to the tune of SEK 9 (-) million.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC